Clinical Trial: Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase I/II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Brief Summary:
To determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery.Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains controlled).
Read more